<SEC-DOCUMENT>0001104659-25-103689.txt : 20251029
<SEC-HEADER>0001104659-25-103689.hdr.sgml : 20251029
<ACCEPTANCE-DATETIME>20251029151138
ACCESSION NUMBER:		0001104659-25-103689
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251029
DATE AS OF CHANGE:		20251029

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CalciMedica, Inc.
		CENTRAL INDEX KEY:			0001534133
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				452120079
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91725
		FILM NUMBER:		251429593

	BUSINESS ADDRESS:	
		STREET 1:		505 COAST BOULEVARD SOUTH
		STREET 2:		SUITE 307
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-952-5500

	MAIL ADDRESS:	
		STREET 1:		505 COAST BOULEVARD SOUTH
		STREET 2:		SUITE 307
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CalciMedica, Inc. /DE/
		DATE OF NAME CHANGE:	20230322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAYBUG VISION, INC.
		DATE OF NAME CHANGE:	20170717

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAYBUG, Inc.
		DATE OF NAME CHANGE:	20150303

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bering Partners II GP, L.L.C.
		CENTRAL INDEX KEY:			0001811744
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		ONE MARITIME PLAZA
		STREET 2:		SUITE 2250
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		650-387-5779

	MAIL ADDRESS:	
		STREET 1:		ONE MARITIME PLAZA
		STREET 2:		SUITE 2250
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Bering Partners II GP, L.L.C. -->
          <cik>0001811744</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, par value $0.0001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>01/23/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001534133</issuerCik>
        <issuerName>CalciMedica, Inc.</issuerName>
        <issuerCusip>38942Q202</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>505 Coast Boulevard South</com:street1>
          <com:street2>Suite 307</com:street2>
          <com:city>La Jolla</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92037</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bering Partners II, L.P. ("Bering II")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>663246.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>663246.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>663246.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.8</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>Note to row 5, 7 and 9: 663,246 shares, except that Bering Partners II GP, L.L.C., the general partner of Bering II ("Bering II GP"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Bering II and Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer"), the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024.  With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bering Partners II GP, L.L.C. ("Bering II GP")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>663246.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>663246.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>663246.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.8</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Note to row 5, 7 and 9: 663,246 shares, of which all are directly owned by Bering II.  Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares.  Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024.  With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Evgeny Zaytsev ("Zaytsev")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>663246.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>663246.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>663246.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.8</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Note to row 6, 8 and 9: 663,246 shares, of which all are directly owned by Bering II.  Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares and Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024.  With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Philip Sawyer ("Sawyer")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>663246.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>663246.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>663246.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.8</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Note to row 6, 8 and 9: 663,246 shares, of which all are directly owned by Bering II.  Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares and Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024.  With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>CalciMedica, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>505 Coast Boulevard South, Suite 307, La Jolla, CA 92037</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Statement is filed by Bering Partners II, L.P. ("Bering II"), Bering Partners II GP, L.L.C., a Delaware limited liability company ("Bering II GP"), Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer").  The foregoing entities and individuals are collectively referred to as the "Reporting Persons."

Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote and sole power to dispose of shares of the issuer directly owned by Bering II.

Zaytsev and Sawyer are managing members of Bering II GP and may be deemed to have shared power to vote and shared power to dispose of shares of the issuer directly owned by Bering II.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Bering Capital
601 California Street, Suite 620
San Francisco, CA 94108</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Bering II is a Delaware limited partnership.  Bering II GP is a Delaware limited liability company.  Zaytsev and Sawyer are United States citizens.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See Row 9 of cover page for each Reporting Person</amountBeneficiallyOwned>
        <classPercent>See Row 11 of cover page for each Reporting Person</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See Row 5 of cover page for each Reporting Person</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See Row 6 of cover page for each Reporting Person</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See Row 7 of cover page for each Reporting Person</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See Row 8 of cover page for each Reporting Person</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>Under certain circumstances set forth in the limited partnership agreement of Bering II, and the limited liability company agreement of Bering II GP, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the issuer owned by each such entity of which they are a partner or member, as the case may be.</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Bering Partners II, L.P. ("Bering II")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Evgeny Zaytsev</signature>
        <title>Managing Member of the General Partner</title>
        <date>10/29/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Bering Partners II GP, L.L.C. ("Bering II GP")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Evgeny Zaytsev</signature>
        <title>Managing Member</title>
        <date>10/29/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Evgeny Zaytsev ("Zaytsev")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Evgeny Zaytsev</signature>
        <title>Evgeny Zaytsev</title>
        <date>10/29/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Philip Sawyer ("Sawyer")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Philip Sawyer</signature>
        <title>Philip Sawyer</title>
        <date>10/29/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
